Article

COVID-19: Impact of pandemic on Switzerland's ophthalmic space

Author(s):

Alex Delaney-Gesing

Roberto Pinelli, MD, CEO, and founder of the Switzerland Eye Research Institute, shares how operations at the facility have adapted to the growing coronavirus pandemic spreading across the globe.

 

See more coronavirus coverage

Related Videos
2 experts are featured in this series.
Related Content
Ophthalmology Times 2024 wrap-up: A year of innovation and insight
December 26th 2024

Ophthalmology Times 2024 wrap-up: A year of innovation and insight

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Targeting IL-6 inflammation: A promising frontier in treating thyroid eye disease
December 26th 2024

Targeting IL-6 inflammation: A promising frontier in treating thyroid eye disease

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Exploring electrical stimulation therapy: A promising approach to vision loss in optic neuropathies
Published: December 26th 2024 | Updated: December 26th 2024

Exploring electrical stimulation therapy: A promising approach to vision loss in optic neuropathies

Study: Diabetes does not significantly impact outcomes of epiretinal membrane surgery
Published: December 26th 2024 | Updated: December 26th 2024

Study: Diabetes does not significantly impact outcomes of epiretinal membrane surgery

© 2024 MJH Life Sciences

All rights reserved.